
Uterine fibroids—noncancerous growths that develop on the uterus—are thought to affect between 70 % and 80 % of women in the United States. Despite their prevalence, the condition remains largely unspoken, under‑researched and underfunded.
Fibroids can lead to heavy menstrual bleeding, pelvic pain, bloating and problems with fertility. Yet many women, including public figures such as tennis champion Venus Williams and actress Lupita Nyong’o, endure the symptoms in silence for years.
Dr. Soyini Hawkins, a board‑certified gynecologist who specializes in fibroids, co‑founded the Fibroid and Pelvic Wellness Center of Georgia and co‑authored the book *From Fibroids to Freedom, From Silence to Strength*. She knows personally how the disorder can affect a woman’s mental health, physical well‑being and finances.
On this week’s episode of “Healthful,” Dr. Hawkins explained what triggers fibroids, why they need not end a woman’s fertility plans, and how patients can speak up for themselves during medical appointments.
In the simplest terms, Hawkins described a fibroid as “a benign tumor that grows from the muscle of the uterus.” Any woman of reproductive age can develop one.
Not every fibroid causes symptoms, but those that do may alter menstrual flow, cause heavy bleeding, pain or even infertility. Large fibroids can change the shape of the waist, making clothing fit differently. Their location matters as well.
“It’s like real estate—location, location, location,” Hawkins said. “Where the fibroid sits influences the symptoms a patient experiences.”
According to Hawkins, hormones are the primary driver. The same hormones that enable pregnancy also promote fibroid growth, a pattern also seen in conditions such as endometriosis and polycystic ovary syndrome.
“Hormones are what I call our claim to fame,” she explained. “When they’re balanced they give us our femininity—our ability to carry babies, our curves, our sensuality. When they’re out of balance they can help tumors like fibroids develop in the uterus.”
Although tens of millions of women live with fibroids, the disorder receives little public attention. Federal research funding reflects that disparity: the National Institutes of Health allocates money to roughly 3,000 conditions, and fibroids rank in the bottom 40. Only about $17 million a year is earmarked for fibroid research.
When the broader economic impact is considered—lost productivity, missed promotions, blood transfusions, hospital stays and the cost of medical supplies—the burden is “tremendous,” Hawkins noted. Research estimates the annual cost at $34.4 billion, more than the combined expenses for ovarian, breast and colon cancers.
Black women are affected two to three times more often than White women, and they often experience more severe symptoms. Hawkins pointed to vitamin D deficiency as a key factor in this disparity. Higher melanin levels reduce the skin’s ability to synthesize vitamin D from sunlight, which can influence fibroid growth.
“There’s a direct connection between vitamin D and how fibroids develop,” she said, recommending that all women, regardless of skin tone, consider a vitamin D supplement for both fibroid prevention and overall health.
“We normalize our suffering because we feel we have to push through, care for our families, perform at work and not be sidelined by our periods,” Hawkins observed.
Many women are unaware that fibroids can be treated. Hawkins herself did not learn she had fibroids until a routine exam revealed a uterus twice the normal size.
The first step is straightforward: an ultrasound. The test is inexpensive, non‑invasive and painless, and most gynecologists can perform it in office. If something seems to be changing, Hawkins advises asking for imaging “even if it’s just to reassure yourself that everything is okay.”
A diagnosis does not automatically mean a hysterectomy. While uterine fibroids are the leading cause of hysterectomies in the United States, Hawkins rejects the notion that removal of the uterus is the default.
“I refuse to say a hysterectomy is the standard of care. It shouldn’t be,” she said.
A myomectomy—surgical removal of the fibroids while preserving the uterus—can be equally effective. The procedure can be done through a minimally invasive laparoscopic approach, via a non‑invasive technique, or with newer radiofrequency ablation that uses heat to shrink the growths. The best option depends on the fibroids’ size and position, the woman’s symptoms and her future child‑bearing plans.
A common fear is that fibroids will jeopardize fertility. Hawkins wants prospective mothers to retain hope. In her experience, many women first learn they have fibroids during an early‑pregnancy ultrasound.
Hawkins herself underwent a myomectomy, kept her uterus intact and later gave birth to two children.
Looking ahead, she is optimistic about advances in fibroid care but stresses that progress hinges on women advocating for themselves and demanding better treatment.
“Advocate by understanding what your body is going through, note any changes, and bring them to your doctor. If you need a second, third or even fifth opinion because you’re not being heard, go for it,” she urged.
On average, women wait up to four years before seeking medical help for fibroids. Hawkins attributes part of that delay to cultural conditioning that teaches women to accept pain as a normal part of being female, to push through illness and to prioritize others over themselves.
She concludes that women do not have to endure fibroids in silence. “Come to the doctor, share your concerns, and don’t stay home in the quiet,” she said.